Chest X-Ray Scoring System in COVID-19 Pneumonia: An Added Value in the Evaluation of the Disease Severity
Objectives: To analyze the added value of a new CXR scoring system in the evaluation of the COVID-19 pneumonia severity.
Methods: This retrospective study included, from March to April 2020, 169 (132M/37F) hospitalized COVID-19 patients, mean age 65.6±10.8 years; 57 had low-pressure ventilation (Group A), 50 positive-pressure ventilation (Group B) and 62 invasive ventilation (Group C). Two radiologists in consensus evaluated the CXRs using an 18-points scoring system. CXR scores were compared in each Group and among the three Groups. Then in each Group CXR scores were correlated with Pa02/Fi02 and, in Group C, with Simplified Acute Physiology Score (SAPS). Non-parametric tests were used.
Results: In Group A the median score at admission was 8 [Interquartile range (IR) 7-9] and the median of the highest scores was 9 [IR 8-10](p=0.0738). Median scores at admission and before the start of the ventilation (pre-ventilation) are resulted, in Group B, 10 [IR 8-10] and 11 [IR 10-14](p<0.0001) and, in Group C, 10 [IR 8-11] and 12 [IR 11-13](p<0.0001). In Group A the CXR scores at admission were lower than in Group C (p=0.0257), and the highest scores were lower than the pre-ventilation ones of Groups B (p=0.0018) and C (p=0.0001). The CXR scores correlated negatively with Pa02/Fi02 and positively with SAPS.
Conclusion: CXR scoring system could be an added value in the evaluation of COVID-19 pneumonia severity. With lowpressure ventilation, the CXR scores were lower than with positive-pressure and invasive ventilation. Furthermore, CXR scores showed negative correlation with Pa02/Fi02 and positive with SAPS. Implications for practice: This new CXR scoring system could be a useful diagnostic tool to quantify the COVID-19 pneumonia severity and to guide to choice of the correct ventilation support.
1.Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al.China Novel Coronavirus Investigating and Research Team. A novel Coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727–33.
2. Sun P, Lu X, Xu C, Sun W, Pan B. Understanding of COVID-19 based on current evidence. J Med Virol 2020;92:548–51.
3. Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, Zhang LJ. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology 2020;296:E15–E25.
4. Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA, Zhang N, et al. Chest CT findings in Coronavirus disease-19 (COVID-19): Relationship to duration of infection. Radiology 2020;295:200463.
5. Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. Time course of lung changes at chest CT during recovery from Coronavirus disease 2019 (COVID-19). Radiology 2020;295:715–21.
6. Rubin GD, Ryerson CJ, Haramati LB, Sverzellati N, Kanne JP, Raoof S, et al. The role of chest imaging in patient management during the COVID-19 pandemic: a multinational consensus statement from the Fleischner Society. Chest 2020; 158:106–16.
7. Zhang HW, Yu J, Xu HJ, Lei Y, Pu ZH, Dai WC, et al. Corona virus international public health emergencies: implications for radiology management. Acad Radiol 2020;27:463–7.
8. Cozzi D, Albanesi M, Cavigli E, Moroni C, Bindi A, Luvarà S, et al. Chest X-ray in new Coronavirus disease 2019 (COVID-19) infection: findings and correlation with clinical outcome. Radiol Med 2020;125:730–7.
9. ACR Recommendations for the use of Chest Radiography and Computed Tomography (CT) for Suspected COVID-19 Infection. American College of Radiology 2020. Available at: https://www.acr.org/Advocacy-and-Economics/ACR-Position-Statements/Recommendations-for-Chest-Radiography-and-CT-for-Suspected-COVID19-Infection. Accessed Nov 29, 2021.
10. Lone SA, Ahmad A. COVID-19 pandemic - an African perspective. Emerg Microbes Infect 2020;9:1300–8.
11. Wong HYF, Lam HYS, Fong AH, Leung ST, Chin TW, Lo CSY, et al. Frequency and distribution of chest radiographic findings in patients positive for COVID-19. Radiology 2020;296:72–8.
12. Toussie D, Voutsinas N, Finkelstein M, Cedillo MA, Manna S, Maron SZ, et al. clinical and chest radiography features determine patient outcomes in young and middle-aged adults with COVID-19. Radiology 2020;297;197–6.
13. Liu X, Zhou H, Zhou Y, Wu X, Zhao Y, Lu Y, Tan W, Yuan M, Ding X, Zou J, Li R,. Temporal radiographic changes in COVID-19 patients: relationship to disease severity and viral clearance. Sci Rep 2020;10:10263.
14. Borghesi A, Maroldi R. COVID-19 outbreak in Italy: experimental chest X-ray scoring system for quantifying and monitoring disease progression. Radiol Med 2020;125:509–13.
15. Borghesi A, Zigliani A, Masciullo R, Golemi S, Maculotti P, Farina D, et al. Radiographic severity index in COVID-19 pneumonia: relationship to age and sex in 783 Italian patients. Radiol Med 2020;125:461–4.
16. Fraiman JB. Chest CT and Coronavirus disease (COVID-19): a more complete review. AJR Am J Roentgenol 2020;215:W35.
17. De Barry O, Obadia I, El Hajjam M, Carlier RY. Chest-X-ray is a mainstay for follow-up in critically ill patients with covid-19 induced pneumonia. Eur J Radiol 2020;129:109075.
18. Schiaffino S, Tritella S, Cozzi A, Carriero S, Blandi L, Ferraris L, et al. Diagnostic performance of Chest X-Ray for COVID-19 pneumonia during the SARS-CoV-2 pandemic in lombardy, Italy. J Thorac Imaging 2020;35:105–6.
19. Wang X, Hu X, Tan W, Mazzone P, Mireles-Cabodevila E, Han X, et al. Multicenter study of temporal changes and prognostic value of a CT visual severity score in hospitalized patients with Coronavirus disease (COVID-19). AJR Am J Roentgenol 2020;217:83–92.
20. Erturk SM, Durak G, Ayyildiz H, Comert RG, Medetalibeyoglu A, Senkal N, et al. A Covid-19: correlation of early chest computed tomography findings with the course of disease. J Comput Assist Tomogr 2020;44:633–9.